SCHEMBL5147306

SCHEMBL5147306

O=CCc1cc(Cl)c(Cl)s1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.38
DAO P14920 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824057 0.79 GSK3B (0.32) GSK3B
SCHEMBL5543849 0.74 GSK3B (0.35) GSK3BDAO
SCHEMBL3714951 0.74 VCAM1 (0.38)
SCHEMBL9768926 0.72
SCHEMBL10078226 0.70
SCHEMBL7368227 0.70
SCHEMBL5009882 0.70
SCHEMBL13857947 0.69 HDAC3 (0.46)
SCHEMBL10998017 0.68 GSK3B (0.46) GSK3BDAO
SCHEMBL10582977 0.67 MEN1 (0.49) GSK3BDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed